| Product NDC: | 0173-0524 |
| Proprietary Name: | IMITREX |
| Non Proprietary Name: | sumatriptan |
| Active Ingredient(s): | 5 mg/1 & nbsp; sumatriptan |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0524 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020626 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19971010 |
| Package NDC: | 0173-0524-00 |
| Package Description: | 6 CONTAINER in 1 BOX (0173-0524-00) > 1 SPRAY in 1 CONTAINER |
| NDC Code | 0173-0524-00 |
| Proprietary Name | IMITREX |
| Package Description | 6 CONTAINER in 1 BOX (0173-0524-00) > 1 SPRAY in 1 CONTAINER |
| Product NDC | 0173-0524 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sumatriptan |
| Dosage Form Name | SPRAY |
| Route Name | NASAL |
| Start Marketing Date | 19971010 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | SUMATRIPTAN |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |